Smart Capital Traders
  • Politics
  • Investing
  • Latest News
  • Stocks

Smart Capital Traders

  • Politics
  • Investing
  • Latest News
  • Stocks
Politics

House investigators nix Mueller testimony in Epstein probe over health concerns

by admin August 30, 2025
August 30, 2025
House investigators nix Mueller testimony in Epstein probe over health concerns

House investigators’ plan to grill former FBI Director Robert Mueller has hit a snag. 

The House Oversight Committee was set to have Mueller appear before the panel on Tuesday as part of the House’s probe into Jeffrey Epstein. However, a source familiar with the investigation told Fox News Digital that lawmakers ‘learned that Mr. Mueller has health issues that preclude him from being able to testify.’ 

‘The committee intends to withdraw its subpoena,’ the source said. 

Mueller was one of many notable figures, including the Clintons, who House Oversight Committee Chair James Comer, R-Ky., subpoenaed to testify before the panel. 

He would have been the second witness appearing in-person before the House Oversight Committee after former Attorney General Bill Barr did so last month.

His closed-door deposition was expected to see at least some lawmakers on both sides attend, with the investigation so far seeing wide bipartisan support in an otherwise highly divided era for Congress.

Mueller was most recently in the headlines for his role as special counsel investigating whether Russia interfered in the 2016 election in favor of President Donald Trump.

That probe, which did not find Trump to have committed any wrongdoing, saw 34 people indicted and eight convictions or guilty pleas, including several people associated with the president.

House investigators were expected to dive into Mueller’s time as director of the FBI. He led the bureau under former Presidents George W. Bush and Barack Obama, from September 2001 until September 2013.

It was during that window that the federal government first investigated Epstein, something Comer pointed out in his letter subpoenaing Mueller.

‘When you were FBI Director, an FBI investigation of Mr. Epstein led to an Assistant U.S. Attorney in the Southern District of Florida preparing a draft 60-count indictment of Mr. Epstein in 2007,’ Comer wrote.

‘However, the next year, Mr. Epstein pled guilty in Florida state court to two prostitution offenses, and, in exchange, he and his co-conspirators received immunity from federal prosecution through a non-prosecution agreement.’

That non-prosecution agreement has been widely criticized and is now the basis for Epstein accomplice Ghislaine Maxwell to appeal her conviction and 20-year prison sentence before the Supreme Court.

It’s not clear how much of a role Mueller would have had in that agreement. Alexander Acosta, the former Trump labor secretary and U.S. attorney in Florida who signed off on the deal, is sitting down with the House Oversight Committee for a voluntary transcribed interview later this month.

Comer sent out a flurry of subpoenas last month in relation to the Epstein probe. 

Other figures also compelled to appear after Mueller are former FBI Director James Comey, former Attorney General Loretta Lynch and ex-first couple Bill and Hillary Clinton.

This post appeared first on FOX NEWS

previous post
Legal group sues FDA over puberty blocker records, citing alleged Biden-era cover-up
next post
Is Putin stringing Trump along to sidestep US sanctions while bombing Ukraine?

related articles

Gabbard says Comey should be ‘put behind bars’...

May 16, 2025

Future of Trump budget bill uncertain as House...

April 9, 2025

Trump admin scores legal win in $16B climate...

September 3, 2025

South African-born Musk evoked by Trump during meeting...

May 22, 2025

MORNING GLORY: President Trump has just issued an...

January 23, 2025

Democrats need new playbook to confront Trump, Kamala...

December 14, 2024

White House monitoring reports of North Korean soldiers...

October 22, 2024

Republicans scrap deal in ‘big, beautiful bill’ to...

July 1, 2025

Federal judge temporarily blocks shutdown of US-funded radio...

March 26, 2025

DEROY MURDOCK: I was at the Trump Madison...

October 30, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Most Popular

    • 1

      Bold Ventures Announces Final Closing of Non-Brokered Private Placement and Insider Subscriptions

      October 19, 2024
    • 2

      Retraction of Forecast Financial Information Plus Announcement on New Metallurgical Testwork Results

      October 15, 2024
    • 3

      As North Korea, Iran and China support Russia’s war, is a ‘new axis’ emerging?

      October 25, 2024
    • 4

      Lode Gold Launches Exploration Program at One of the Largest Land Packages in New Brunswick

      October 19, 2024
    • 5

      Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology

      October 31, 2024

    Categories

    • Investing (2,384)
    • Latest News (2,300)
    • Politics (2,895)
    • Stocks (934)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: smartcapitaltraders.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 smartcapitaltraders.com | All Rights Reserved